1. Home
  2. LC vs EVO Comparison

LC vs EVO Comparison

Compare LC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LC
  • EVO
  • Stock Information
  • Founded
  • LC 2006
  • EVO 1993
  • Country
  • LC United States
  • EVO Germany
  • Employees
  • LC N/A
  • EVO N/A
  • Industry
  • LC Finance: Consumer Services
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LC Finance
  • EVO Health Care
  • Exchange
  • LC Nasdaq
  • EVO Nasdaq
  • Market Cap
  • LC 1.7B
  • EVO 1.4B
  • IPO Year
  • LC 2014
  • EVO 2021
  • Fundamental
  • Price
  • LC $16.30
  • EVO $3.64
  • Analyst Decision
  • LC Buy
  • EVO Buy
  • Analyst Count
  • LC 6
  • EVO 2
  • Target Price
  • LC $16.83
  • EVO $5.40
  • AVG Volume (30 Days)
  • LC 2.5M
  • EVO 51.1K
  • Earning Date
  • LC 07-29-2025
  • EVO 08-13-2025
  • Dividend Yield
  • LC N/A
  • EVO N/A
  • EPS Growth
  • LC 68.10
  • EVO N/A
  • EPS
  • LC 0.64
  • EVO N/A
  • Revenue
  • LC $1,248,526,000.00
  • EVO $912,894,891.00
  • Revenue This Year
  • LC N/A
  • EVO $1.13
  • Revenue Next Year
  • LC $19.23
  • EVO $9.67
  • P/E Ratio
  • LC $25.43
  • EVO N/A
  • Revenue Growth
  • LC 15.90
  • EVO N/A
  • 52 Week Low
  • LC $7.90
  • EVO $2.84
  • 52 Week High
  • LC $18.75
  • EVO $5.64
  • Technical
  • Relative Strength Index (RSI)
  • LC 66.65
  • EVO 39.42
  • Support Level
  • LC $14.61
  • EVO $3.50
  • Resistance Level
  • LC $16.16
  • EVO $3.74
  • Average True Range (ATR)
  • LC 0.63
  • EVO 0.08
  • MACD
  • LC -0.07
  • EVO -0.02
  • Stochastic Oscillator
  • LC 84.50
  • EVO 29.17

About LC LendingClub Corporation

LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: